Dr. Ourania S. Kotsiou is an Assistant Professor of Human Pathophysiology at the University of Thessaly, specializing in respiratory diseases. She earned her PhD from the University of Thessaly, focusing on biomarkers in pleural diseases. Her expertise includes research in asthma, COPD, and the role of exosomes in airway inflammation. Dr. Kotsiou combines clinical practice with research and has been honored with numerous awards for her contributions to pulmonary medicine.
Publication profile
Orcid
Scholar
Evaluation of Dr. Ourania S. Kotsiou for the Best Researcher Award
🏆 Strengths for the Award:
Expertise in Respiratory Diseases: Dr. Kotsiou’s extensive research in asthma, COPD, and pleural effusion showcases her deep expertise in respiratory medicine, particularly in understanding molecular mechanisms and developing innovative therapies such as anti-IL-5 biologics. High Research Output: With 90 publications in reputable journals (PubMed-indexed) and a substantial total impact factor of 549.663, her contributions have significantly advanced pulmonary research. Her h-index of 16 and i10-index of 29 underscore the quality and influence of her research. Leadership in Research Projects: Dr. Kotsiou has led multiple high-impact research projects, including a GlaxoSmithKline-funded study on severe asthma, which highlights her ability to manage and contribute to cutting-edge research in the field. Strong Academic Presence: As an Assistant Professor at the University of Thessaly, she has an established academic profile, contributing to both teaching and research, while also collaborating with prestigious organizations such as the European Respiratory Society (ERS). Editorial Contributions: Her involvement as an editorial board member and guest editor for international journals, such as Scientific Reports (Nature), demonstrates her leadership and recognition in the academic community.
🔧 Areas for Improvements:
Patent Applications: Dr. Kotsiou does not currently hold any patents, which could enhance her profile by highlighting her contributions to innovative treatment methods or diagnostic tools in pulmonary medicine. Public and Community Outreach: Increased involvement in community outreach programs or extension activities related to public health awareness and respiratory disease prevention could strengthen her candidacy for awards related to societal impact.
📖 Books Published (ISBN)
Contributor to 16 book sections or chapters.
🏆 Contributions
Dr. Kotsiou has made significant strides in understanding asthma and COPD, focusing on molecular mechanisms and innovative therapies like anti-IL-5 biologics. Her research has influenced better treatment approaches, enhancing patient outcomes.
💡 Research and Innovations:
Completed/Ongoing Research Projects: Chief Investigator: GlaxoSmithKline-funded study on severe asthma and anti-IL-5 treatment (2020-2024). Sub-Investigator: PRINCIPLE, PRECURSOR, PHOLLOW, ISABELA1 studies (2019-2024). Research Fellow in HTS-funded projects on COPD and asthma. Citation Index: 1136 (Google Scholar), h-index: 16, i10-index: 29. Consultancy/Industry Projects: Collaborations with Pfizer, AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline.
Publication top notes
- Title: IL-33/ST2 axis in organ fibrosis
Authors: OS Kotsiou, KI Gourgoulianis, SG Zarogiannis
Journal: Frontiers in Immunology
Year: 2018
Volume/Issue: 9, 2432
- Title: Acceptability of COVID-19 vaccination among Greek health professionals
Authors: D Papagiannis, G Rachiotis, F Malli, IV Papathanasiou, O Kotsiou, et al.
Journal: Vaccines
Year: 2021
Volume/Issue: 9(3), 200
- Title: Impact of the refugee crisis on the Greek healthcare system: a long road to Ithaca
Authors: OS Kotsiou, P Kotsios, DS Srivastava, V Kotsios, KI Gourgoulianis, et al.
Journal: International Journal of Environmental Research and Public Health
Year: 2018
Volume/Issue: 15(8), 1790
- Title: Pulmonary function testing in COPD: looking beyond the curtain of FEV1
Authors: S Kakavas, OS Kotsiou, F Perlikos, M Mermiri, G Mavrovounis, et al.
Journal: NPJ Primary Care Respiratory Medicine
Year: 2021
Volume/Issue: 31(1), 23
- Title: Calprotectin in lung diseases
Authors: OS Kotsiou, D Papagiannis, R Papadopoulou, KI Gourgoulianis
Journal: International Journal of Molecular Sciences
Year: 2021
Volume/Issue: 22(4), 1706
- Title: The emergency medical system in Greece: Opening Aeolus’ bag of winds
Authors: OS Kotsiou, DS Srivastava, P Kotsios, AK Exadaktylos, KI Gourgoulianis
Journal: International Journal of Environmental Research and Public Health
Year: 2018
Volume/Issue: 15(4), 745
- Title: Prehospital NSAIDs use prolong hospitalization in patients with pleuro-pulmonary infection
Authors: OS Kotsiou, SG Zarogiannis, KI Gourgoulianis
Journal: Respiratory Medicine
Year: 2017
Volume/Issue: 123, 28-33
- Title: Estimates of COVID-19 risk factors among social strata and predictors for vulnerability to infection
Authors: DS Mouliou, OS Kotsiou, KI Gourgoulianis
Journal: International Journal of Environmental Research and Public Health
Year: 2021
Volume/Issue: 18(16), 8701
- Title: Impact of the financial crisis on COPD burden: Greece as a case study
Authors: OS Kotsiou, S Zouridis, M Kosmopoulos, KI Gourgoulianis
Journal: European Respiratory Review
Year: 2018
Volume/Issue: 27(147)
- Title: Action and reaction of pre-primary and primary school-age children to restrictions during the COVID-19 pandemic in Greece
Authors: DI Siachpazidou, OS Kotsiou, G Chatziparasidis, D Papagiannis, et al.
Journal: Journal of Personalized Medicine
Year: 2021
Volume/Issue: 11(6), 451
📋 Conclusion:
Dr. Ourania S. Kotsiou is a highly qualified candidate for the Best Researcher Award due to her impactful research in respiratory diseases, leadership in significant clinical projects, and strong academic contributions. With a focus on further extending her innovations into patents or public health initiatives, her influence in both the academic and medical community will continue to grow. She exemplifies the qualities of a leading researcher dedicated to advancing pulmonary health.